Molecular and imaging correlates of exceptional pathologic response to neoadjuvant ADT plus enzalutamide.

Abstract

61Background: AR directed therapies are standard of care for metastatic prostate cancer, and their use for high-risk localized disease may improve survival. Previous trials showed that suppression ...